Consortium board

Jennifer Keiser

Jennifer Keiser is an Assistant Professor at the Department of Medical Parasitology and Infection Biology at the Swiss Tropical and Public Health Institute (Swiss TPH). She is heading the Helminth Drug Development Unit, which maintains many helminth rodent models including Schistosoma mansoni. Research objectives of her team include in vitro and in vivo evaluation of compounds, preclinical studies such as pharmacokinetics and metabolism, mechanism of action studies and clinical trials in endemic countries.

Ton Rijnders

Ton Rijnders became Scientific Director of Lygature (formerly Top Institute Pharma) in 2011. He started his career in industry at Organon in 1986, where he held several management positions. After the acquisition by Schering-Plough and later Merck, he was appointed VP Discovery and Site Head Oss. Ton Rijnders holds a PhD in Molecular Biology, and is member of several scientific and professional societies. In addition, from 2013 onwards Ton is also Head of the European Screening Centre, part of the IMI European Lead Factory.  

Jutta Reinhard-Rupp

Jutta Reinhard-Rupp holds a PhD in biology and has more than 15 years of drug discovery and development experience in the pharmaceutical and biotech industry. She was responsible for genomics and pharmaco-genomics departments at Aventis and led several development projects as project director in Sanofi-Aventis. Jutta is working in the healthcare business of Merck KGaA, Darmstadt, Germany, as senior director of the Global Health department with a strong focus on “infectious diseases” and “childcare” projects.

Peter Bonate has more than 20 years industry experience and is currently the Executive Director of the Pharmacokinetics, Modeling, & Simulation Group at Astellas.  He has a PhD in Medical Neurobiology, an MS in Statistics, and an MS in Pharmacology/Toxicology.  He is a fellow of the American Association of Pharmaceutical Scientists (AAPS) and American College of Clinical Pharmacology.  An expert in clinical pharmacology and the mathematical modeling of clinical and pharmacokinetic data, in 2015, he was the recipient of the Clinical Pharmacology and Translation Research Achievement Award from AAPS.

Bárbara Ferreira Trigueiros

Bárbara Ferreira Trigueiros is a coordinator at Department of Technological Development Management at the Farmanguinhos, a unit of Fiocruz Fundation (Rio de Janeiro, Brazil). She is heading the tech transfer projects, in special of biotech and synthetics medicines. Her team develops and absorbs technologies demanded by Ministry of Health. Post graduated and master’s in clinical and experimental pathophysiology, she has been working in the public pharmaceutical industry since 2001.